ADC Therapeutics (ADCT) Return on Sales [ROS] (2021 - 2026)
ADC Therapeutics (ADCT) recorded Return on Sales [ROS] of -132.03% in Q2 2026, up 102.30 percentage points from -234.34% a year earlier but down 10.96 percentage points from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
On a TTM basis, ADC Therapeutics' Return on Sales [ROS] came in at -166.89% as of Jun 30, 2026, up 9.60 percentage points year-over-year.
- Quarterly Return on Sales [ROS] has ranged from -439.58% in Q3 2021 to -4.08% in Q3 2022 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] rose in five of the last six quarters, with an average year-over-year change of +26.80 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 1473.09 percentage points in Q2 2022, against a drop of 245.34 percentage points in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | ADC Therapeutics | 142.73 Mn | -803.46 Mn | 16.90 Mn | -132.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -132.03% |
| Mar 31, 2026 | -121.07% |
| Sep 30, 2025 | -188.52% |
| Jun 30, 2025 | -234.34% |
| Mar 31, 2025 | -123.58% |
| Sep 30, 2024 | -192.61% |
| Jun 30, 2024 | -166.81% |
| Mar 31, 2024 | -186.19% |
| Sep 30, 2023 | -249.42% |
| Jun 30, 2023 | -205.62% |
| Mar 31, 2023 | -271.55% |
| Sep 30, 2022 | -4.08% |
| Jun 30, 2022 | -401.43% |
| Mar 31, 2022 | -86.81% |
| Sep 30, 2021 | -439.58% |
| Jun 30, 2021 | -1,874.52% |
API Access
ADC Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();